APOA5 and metabolic dysfunction-associated steatotic liver disease: In spite of the above limitations, we first found that the ApoA5 levels and the prevalence of hypertriglyceridemia are in an inverted “U-shaped” correlation, but there is no significant difference between the ApoA5 levels, NAFLD, and metabolic syndrome.